Beta-Glucan Market is forecasted to value over USD 703.1 million by 2028 end and register a CAGR of 7.5% from the forecast period 2021-2028.

The report on Beta-Glucan Market by Future Market Analytics consists of the Beta-Glucan Market trends like automation of irrigational techniques, the huge demand for organic foods, etc. that has the capability of transforming the market augmentation scenario. Moreover, the report includes detailed insights on the overall Beta-Glucan Market share, the markets impact on industry verticals pertaining to revenue management, business expansion, and real-time process refinement, etc. The report also includes the competitive landscape ranging from key market players to new entrants and their SWOT analysis along with the market analysis pertaining to regions such as North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

Furthermore, the report will include the key player growth matrix and market growth matrix which shall visually represent the market position of important market players. This report will also provide insights on the latest mergers and acquisitions along with market entry strategies for new entrants and emerging players. The list of primary research sources and contacts used for this study are also included in this report. With the assistance of the latest market research methodologies, the market analysts at Future Market Analytics have estimated that the market is anticipated to attain substantial proliferation within the forecasted timeframe. The report includes insights regarding the Beta-Glucan Market size and the current valuation of the market along with detailed insights on the market segmentation and the available opportunities for augmentation in the business vertical.

Major players included in the Beta-Glucan Market:

Cargill, Inc
Tate & Lyle Plc.
Kerry Group Plc.
Frutarom
Koninklijke DSM N.V.
Milliporesigma
Lesaffre Human Care
Garuda International Inc.
Angel Yeast Co. Ltd.
Biotech Betaglucan AS
Ohly Gmbh
AIT Ingredients
Biorigin – Zilor
Ceapro Inc.
Specialty Biotech Co., Ltd.
Super Beta Glucan Life Sciences
Glyconova
Garuda International Inc.
Van Wankum Ingredients
Super Beta Glucan
Leiber Group Gmbh & Co.
Embria Health Sciences LLC
Nutraq
ABAC R&D AG
Nutriscience Innovations
Glucan Corporation
Lallemand
Hangzhou New Asia Biotech Co. Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Beta-Glucan Market Segmentation:
By Source

Grains and Cereal
Mushroom
Yeast
Seaweed

By Category

Soluble Beta-Glucan
Insoluble Beta-Glucan

By Application

Food & Beverage
Personal Care
Pharmaceutical
Dietary Supplement
Animal Feed

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

Beta-Glucan Market Competitive Analysis:

Tier-1 Players
Tier-2 Players
Emerging Players
New Entrants

Future Market Analytics Focus Points:

SWOT Analysis
Key Market Trends
Key Data -Points Affecting Market Growth
Revenue and Forecast Analysis
Growth Opportunities For New Entrants and Emerging Players
Key Player and Market Growth Matrix

Objectives of the Study:

To provide a comprehensive analysis on the beta-glucan market by source, by category, by application and by region
To cater extensive insights on factors influencing the market growth (drivers, restraints, industry-specific restraints, business expansion opportunities)
To anticipate and analyse the market size expansion in key regions- North America, Europe, Asia Pacific, Latin America and Middle East and Africa
To record and evaluate competitive landscape mapping- strategic alliances and mergers, technological advancements and product launches, revenue and financial analysis of key market players

In case of any requirements or changes to the current table of content please contact us at:enquiry@futuremarketanalytics.com

Description

1. Market Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Market Scope
         1.3.1 Years Considered for the Study
         1.3.2 Market Covered
    1.4. Currency
    1.5. Limitations
    1.6. Stakeholders

2. Research Methodology
    2.1. Research Data
         2.1.1. Secondary Data
                2.1.1.1. Key Data from Secondary Sources
         2.1.2. Primary Data
                2.1.2.1. Key Data from Primary Sources
    2.2. Market Size Estimation
    2.3. Market Breakdown and Data Triangulation
    2.4. Assumptions for the Study

3. Executive Summary
    3.1. Market Outlook
    3.2. Segment Outlook
    3.3. Competitive Insights

4. Market Variables, Trends & Scope
    4.1. Market Lineage Outlook
    4.2. Penetration and Growth Prospect Mapping
    4.3. Industry Value Chain Analysis
    4.4. Cost Analysis Breakdown
    4.5. Technology Overview
    4.6. Regulatory Framework on Country Level
         4.6.1. Reimbursement Framework
         4.6.2. Standards and Compliances

5. Market Overview
    5.1. Market Dynamics
         5.1.1. Market Driver Analysis
         5.1.2. Market Restraint Analysis
         5.1.3. Industry Challenges

6. Market Analysis Tools
    6.1. Industry Analysis – Porters
         6.1.1. Supplier Power
         6.1.2. Buyer Power
         6.1.3. Substitution Threat
         6.1.4. Threat from new entrants
         6.1.5. Competitive Rivalry
    6.2. Pestel Analysis
         6.2.1. Political Landscape
         6.2.2. Environmental Landscape
         6.2.3. Social landscape
         6.2.4. Technology landscape
         6.2.5. Legal Landscape

7. Beta-Glucan Market, By Source Historical Analysis 2016-2020 and Forecast 2021-2028 (USD million)
    7.1. Grains and Cereal
    7.2. Mushroom
    7.3. Yeast
    7.4. Seaweed

8. Beta-Glucan Market, By Category Historical Analysis 2016-2020 and Forecast 2021-2028 (USD million)
8.1. Soluble Beta-Glucan
8.2. Insoluble Beta-Glucan

9. Beta-Glucan Market, By Application Historical Analysis 2016-2020 and Forecast 2021-2028 (USD million)
    9.1. Food & Beverage
    9.2. Personal Care
    9.3. Pharmaceutical
    9.4. Dietary Supplement
    9.5. Animal Feed

10. North America Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         10.2.1. U.S.
         10.2.2. Canada
         10.2.3. Mexico
         10.2.4. Rest of North America
    10.3. Market Size (USD Mn) Forecast for North America 2021-2028

11. Latin America Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    11.1. Introduction
    11.2. Regional Market Trends
    11.3. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         11.3.1. Brazil
         11.3.2. Venezuela
         11.3.3. Argentina
         11.3.4. Rest of Latin America
    11.4 Market Size (USD Mn) Forecast for Latin America 2021-2028

12. Europe Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         12.2.1. Germany
         12.2.2. U.K
         12.2.3. France
         12.2.4. Italy
         12.2.5. Switzerland
         12.2.6. Spain
         12.2.7. Russia
         12.2.8. Poland
         12.2.9. Rest of Europe
    12.3. Market Size (USD Mn) Forecast for Europe 2021-2028

13. Asia Pacific Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         13.2.1 Japan
         13.2.2 China
         13.2.3 Singapore
         13.2.4 Korea
         13.2.5 India
         13.2.6 Australia and New Zealand
         13.2.7 ASEAN
         13.2.8 Rest of Asia Pacific
    13.3. Market Size (USD Mn) Forecast for Asia Pacific 2021-2028

14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         14.2.1 UAE
         14.2.2 South Africa
         14.2.3 Egypt
         14.2.4 Saudi Arabia
         14.2.5 Rest of MEA
    14.3. Market Size (USD Mn) Forecast for MEA 2021-2028

15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    15.1. Cargill, Inc
         15.1.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.1.2. Product Portfolio
         15.1.3. SWOT Analysis
         15.1.4. Financial Overview
         15.1.5. Strategic Overview
    15.2. Tate & Lyle Plc.
         15.2.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.2.2. Product Portfolio
         15.2.3. SWOT Analysis
         15.2.4. Financial Overview
         15.2.5. Strategic Overview
    15.3. Kerry Group Plc.
         15.3.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.3.2. Product Portfolio
         15.3.3. SWOT Analysis
         15.3.4. Financial Overview
         15.3.5. Strategic Overview
    15.4. Frutarom
         15.4.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.4.2. Product Portfolio
         15.4.3. SWOT Analysis
         15.4.4. Financial Overview
         15.4.5. Strategic Overview
    15.5. Koninklijke DSM N.V.
         15.5.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.5.2. Product Portfolio
         15.5.3. SWOT Analysis
         15.5.4. Financial Overview
         15.5.5. Strategic Overview
    15.6. Milliporesigma
         15.6.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.6.2. Product Portfolio
         15.6.3. SWOT Analysis
         15.6.4. Financial Overview
         15.6.5. Strategic Overview
    15.7. Lesaffre Human Care
         15.7.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.7.2. Product Portfolio
         15.7.3. SWOT Analysis
         15.7.4. Financial Overview
         15.7.5. Strategic Overview
    15.8. Garuda International Inc.
         15.8.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.8.2. Product Portfolio
         15.8.3. SWOT Analysis
         15.8.4. Financial Overview
         15.8.5. Strategic Overview
    15.9. Angel Yeast Co. Ltd.
         15.9.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.9.2. Product Portfolio
         15.9.3. SWOT Analysis
         15.9.4. Financial Overview
         15.9.5. Strategic Overview
    15.10. Biotech Betaglucan AS
         15.10.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.10.2. Product Portfolio
         15.10.3. SWOT Analysis
         15.10.4. Financial Overview
         15.10.5. Strategic Overview
    15.11. Ohly Gmbh
         15.11.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.11.2. Product Portfolio
         15.11.3. SWOT Analysis
         15.11.4. Financial Overview
         15.11.5. Strategic Overview
    15.12. AIT Ingredients
         15.12.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.12.2. Product Portfolio
         15.12.3. SWOT Analysis
         15.12.4. Financial Overview
         15.12.5. Strategic Overview
    15.13. Biorigin – Zilor
         15.13.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.13.2. Product Portfolio
         15.13.3. SWOT Analysis
         15.13.4. Financial Overview
         15.13.5. Strategic Overview
    15.14. Ceapro Inc.
         15.14.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.14.2. Product Portfolio
         15.14.3. SWOT Analysis
         15.14.4. Financial Overview
         15.14.5. Strategic Overview
    15.15. Specialty Biotech Co., Ltd.
         15.15.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.15.2. Product Portfolio
         15.15.3. SWOT Analysis
         15.15.4. Financial Overview
         15.15.5. Strategic Overview
    15.16. Super Beta Glucan Life Sciences
         15.16.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.16.2. Product Portfolio
         15.16.3. SWOT Analysis
         15.16.4. Financial Overview
         15.16.5. Strategic Overview
    15.17. Glyconova
         15.17.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.17.2. Product Portfolio
         15.17.3. SWOT Analysis
         15.17.4. Financial Overview
         15.17.5. Strategic Overview
    15.18. Garuda International Inc.
         15.18.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.18.2. Product Portfolio
         15.18.3. SWOT Analysis
         15.18.4. Financial Overview
         15.18.5. Strategic Overview
    15.19. Van Wankum Ingredients
         15.19.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.19.2. Product Portfolio
         15.19.3. SWOT Analysis
         15.19.4. Financial Overview
         15.19.5. Strategic Overview
    15.20. Leiber Group Gmbh & Co.
         15.20.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.20.2. Product Portfolio
         15.20.3. SWOT Analysis
         15.20.4. Financial Overview
         15.20.5. Strategic Overview
    15.21. Embria Health Sciences LLC
         15.21.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.21.2. Product Portfolio
         15.21.3. SWOT Analysis
         15.21.4. Financial Overview
         15.21.5. Strategic Overview
    15.22. Nutraq
         15.22.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.22.2. Product Portfolio
         15.22.3. SWOT Analysis
         15.22.4. Financial Overview
         15.22.5. Strategic Overview
    15.23. ABAC R&D AG
         15.23.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.23.2. Product Portfolio
         15.23.3. SWOT Analysis
         15.23.4. Financial Overview
         15.23.5. Strategic Overview
    15.24. Nutriscience Innovations
         15.24.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.24.2. Product Portfolio
         15.24.3. SWOT Analysis
         15.24.4. Financial Overview
         15.24.5. Strategic Overview
    15.25. Glucan Corporation
         15.25.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.25.2. Product Portfolio
         15.25.3. SWOT Analysis
         15.25.4. Financial Overview
         15.25.5. Strategic Overview
    15.26. Lallemand
         15.26.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.26.2. Product Portfolio
         15.26.3. SWOT Analysis
         15.26.4. Financial Overview
         15.26.5. Strategic Overview
    15.27. Hangzhou New Asia Biotech Co. Ltd.
         15.27.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.27.2. Product Portfolio
         15.27.3. SWOT Analysis
         15.27.4. Financial Overview
         15.27.5. Strategic Overview
(Note: The list of the major players will be updated with the latest market scenario and trends)

16. Impact of COVID-19
    16.1. Positive influence on the industry
    16.2. The financial disruption of the sector
    16.3. Impact of COVID-19 on emerging companies
    16.4. Significant mandates in the industry regulations initiated by administrations
    16.5. The overall economic slowdown of the developing and developed nations

17. Competitive Intelligence and Competitive Matrix
17.1. Competitive Intelligence
17.2. Competitive Matrix

18. Major Deals and Strategic Alliances Analysis
    18.1. Joint ventures
    18.2. Mergers and acquisitions
    18.3. Licensing and partnerships
    18.4. Technology Collaborations
    18.5. Strategic Divestments
    18.6. Market Entry Strategies

19. Relevant Case Studies and Latest News Updates

20. Key Market Takeaway Points from the Market Analysts at Future Market Analytics

Beta-Glucan Market By Source, By Category, By Application and By Region: Industry Analysis, Market Share, Revenue Opportunity, Competitive Analysis and Forecast 2021-2028

Description

Beta-Glucan Market By Source, By Category, By Application and By Region: Industry Analysis, Market Share, Revenue Opportunity, Competitive Analysis and Forecast 2021-2028

License Type Details

Need Assistance?

Our Industries

Niche Industries

Useful Links

Company Info